Objective: To investigate the relationship between ankle-branchial index (ABI) and cardiovascular disease in type 2 diabetes patients.
| INTRODUCTION
Atherosclerotic cardiovascular disease (CVD) remains a leading cause of disability and mortality in diabetes population. And Diabetes exacerbates mechanisms underlying atherosclerosis, stroke, and heart failure. 1, 2 Besides coronary arteries, carotid and lower extremity arteries are two other sites where atherosclerotic lesions commonly occur. 3 The multiple correlations and combined diagnosis among coronary, carotid, and lower extremity arteries disease were widely studied and discussed. [4] [5] [6] [7] [8] Previous studies showed that carotid atherosclerotic lesions were an indicator of generalized atherosclerosis. The carotid atherosclerosis detected by ultrasonography was reported to be a potential marker of atherosclerotic disease and independently associated with cardiovascular and cerebrovascular events. [5] [6] [7] Many studies also demonstrated a high prevalence of coronary arterial disease (CAD) in patients with peripheral arterial disease (PAD). 9, 10 Additionally, stable atherosclerotic patients without previous ischaemic events experienced more cardiovascular events. 11 However, the diagnosis value of PAD in predicting CAD was unclear until now.
Diabetic lower extremity atherosclerotic lesion (LEAD) is an important part of diabetic vascular complications. Associated with microvascular lesions and peripheral neuropathy, LEAD often causes lower limb ischaemic necrosis, amputation, and even disability in diabetes population. Ankle-branchial index (ABI) is a kind of noninvasive screening and diagnosis methods of PAD, which was widely used.
Considering the effectiveness and simplicity of ABI detection, we carried out this study to clarify the potential connection between CAD with PAD and assess the screening value of ABI for CAD in Chinese patients with type 2 diabetes. 12 The patient's ABI was determined by lower value of the two sides ABI value. PAD was determined on the basis of a low ABI, and ABI lower than 0.9 was defined as LEAD.
| PATIENTS AND METHODS

| Study population
CAD was diagnosed by a 64-MDCT scanner and medical history of patients. Patients with stenosis that was ≥70% of the epicardial coronary artery in at least one vessel and/or greater than 50% of the left coronary branch or a history of coronary artery stent implantation or bypass grafting were diagnosed as CAD.
| Data collection and anthropometric measurement
Information on sex, age, weight, height, waist circumference, hip circumference, and duration of diabetes and history of smoking, coronary artery disease, hypertension, and cerebral apoplexy were obtained using a questionnaire. The body mass index was calculated as the weight (kg) divided by the square of height (m). Waist-hip ratio was calculated as the waist circumference (cm) divided by the hip circumference (cm). Blood pressure was measured using a sphygmomanometer during a physical examination. Three measures of blood pressure were obtained, with a fourth attempt for those who had a previous measurement interrupted or incomplete. Mean systolic and mean diastolic blood pressure were calculated. ABI to indicate the occurrence of CAD. All P values were two tailed, and P < 0.05 was considered to be statistically significant.
| Statistical analysis
| RESULTS
The study population (n = 634, 327 men and 307 women) had a mean age of 58.43 ± 11.07 years, suffering from type 2 diabetes for 
| Comparison of variables between patients with and without CAD
There were significant differences in age, diabetes TC, HDL-C, LDL-C, Cr, GFR, and ABI between patients with and without CAD (all P < 0.05) ( Table 1 ). The patients in CAD group had significantly lower ABI level than those in the non-CAD group (P < 0.001) ( Figure 1 ).
Besides, the prevalence of CAD in low-ABI group is significantly higher than other two groups (90% vs 33%, 25%; both P < 0.01) ( Figure 1 ), and there was no difference in prevalence of CAD between normal-and high-ABI groups.
| Association of variables with CAD
Spearman correlation analysis showed age, diabetes duration, spontaneous bacterial peritonitis (SBP), TC, TG, LDL-C, Cr, and HbA 1c were positively associated with CAD (all P < 0.05). HDL-C, GFR, and ABI were negatively associated with CAD (all P < 0.05) ( Table 2) .
Moreover, taking normal-ABI group as the referent, we compared the association between ABI and CAD in two statistical models (Table 3 ). In nonadjusted model, a significant association was observed between CAD and low-ABI level (OR, 17.59; 95% CI, 5.22-83.88). In female patients, this OR value was increased to 24.40 (95% CI, 6.79-60.32; both P < 0.01). After adjusted for age, duration, and other associated variables, the positive association between CAD and low-ABI level still existed in male and female (for male: OR, 2.95; 95% CI, 1.02-9.17; for female: OR, 10.63; 95% CI, 3.42-17.82; both P < 0.01). Furthermore, multiple logistic regression analysis showed that the independent risk factors for CAD included age (β = 1.08, P < 0.01), duration (β = 1.06, P = 0.03), TC (β = 1.46, P < 0.01), HDL-C (β = 0.27, P = 0.02), LDL-C (β = 1.27, P = 0.03), HbA 1c (β = 1.02, P = 0.02), and ABI (β = 0.64, P < 0.01).
| The screening value of ABI for CAD
Since ABI was an independent correlative factor for CAD, ROC analysis was performed to reveal the optimal cut-off point of ABI value for predicting CAD in male and female diabetics. When applying ROC analysis, significantly high area under the curve (AUC) values was obtained for ABI (AUC > 0.7). The AUC value was 0.804 (95% CI, 0.730-0.878; P < 0.001). In total, the cut-off point was 1.045. The
Youden index at this level was 0.512; its sensitivity was 79.69%, and the specificity was 71.52% ( Figure 2 ). For men, the cut-off point was also 1.045. The Youden index at this level was 0.462; its sensitivity was 72.21%, and the specificity was 73.98% ( Figure S1a ). For women, the optimal cut-point value was 1.015 (Youden index, 0.677; sensitivity, 89.52%; specificity, 78.23%) ( Figure S1b ).
| DISCUSSION
In this study, we aimed at investigating the link of PAD with CAD, as well as conjecturing the indicating value of ABI for CAD in type 2 diabetic patients. The results of this present cross-sectional study revealed that ABI was observably associated with CAD, and ABI value lower than 1.045 predicted significantly increased risk of the presence of CAD. This suggested that low ABI value is not only an independent associated factor of CAD but also providing us a new potential pathway for screening and treating CAD.
As for the influencing factors of CAD, the results of our study showed a positive association between CAD and age, diabetes 15 Our study demonstrated that the risk of CAD doubled when the ABI value lower than 0.9 in patients with type 2 diabetes, which was compatible with many previous large epidemiological surveys. [16] [17] [18] It was revealed that an ABI between 0.91 and 1.10 was associated with subclinical cardiac and carotid disease and all-cause and CVD mortality. 16, 17 However, our study emphasized a great importance in screening CAD in type 2 diabetes patients with ABI value lower than 1.05, especially in Chinese female. Moreover, there was a difference in ABI value distribution between our result and other findings. We considered that the reason of this difference existing was associated with participants recruitment of studies. The diabetes patients recruited in our study were older and suffering from type 2 diabetes meanly for 9.41 ± 6.24 years. Age and long diabetes duration were high risk factors for atherosclerosis and arteriosteogenesis, which produce much high-or low-ABI value. Besides, the Strong Heart Study reported that the association between high ABI and mortality was similar to that of low ABI and mortality, highlighting a U-shaped association between ABI measure and mortality risk. The author suggested that the upper limit of normal ABI should not exceed 1.40. However, this association between high ABI and CAD was not observed in our study, which might be caused by different high-ABI diagnosis between two studies (>1.3 vs >1.4).
Twelve years ago, Anand V. Doobay and Sonia S. Anand conducted a systematic review of the literature and included studies that used an ABI cut-off between 0.80 and 0.90 to classify patients with or without PAD, followed patients prospectively, and recorded cardiovascular outcomes. A total of 22 studies were identified; 13 were excluded, and 9 studies were included in the meta-analysis. The sensitivity and specificity of a low ABI to predict incident coronary heart diseases were 16.5% and 92.7%, for incident stroke were 16.0% and 92.2%, and for cardiovascular mortality were 41.0% and 87.9%, respectively. The corresponding positive likelihood ratios were 2.53 (95% CI, 1.45-4.40) for coronary heart disease, 2.45 (95% CI, 1.76-3.41) for stroke, and 5.61 (95% CI, 3.45-9.13) for cardiovascular death.
In conclusion, the specificity of a low ABI to predict future cardiovascular outcomes is high, but its sensitivity is low. The ABI should become part of the vascular risk assessment among selected individuals. 19 However, in our type 2 diabetes population, the sensitivity of low ABI for discriminating CAD was over 70% (72.21%). Our crosssectional research not only confirmed that low ABI value is an independent-associated factor of CAD but also detected different ABI cut-off values in predicting the occurrence of CAD for female and male patients with type 2 diabetes. It was revealed that the total and male cut-off point of ABI value for predicting CAD was both 
Cr, μmol/L 0.338 0.000 Abbreviations: ABI, ankle-branchial index; BMI, body mass index; CAD, coronary artery disease; Cr, serum creatinine; CRP, C-reactive protein; DBP, diastolic blood pressure; FCp, fasting C-peptide; FPG, fasting plasma glucose; GA, glycosylated serum protein; GFR, glomerular filtration rate; HbA 1c , glycosylated haemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PPG, 2-hour postprandial blood glucose; SBP, spontaneous bacterial peritonitis; TC, total cholesterol; TG, triglyceride; 2hCp, 2-hour postprandial C-peptide.
1.045, and the female cut-off point value was 1.015, which values were usually considered to be in normal range of ABI. This result indicated that even in patients with normal value of ABI, the risk of CAD had already elevated. Moreover, these three ROC analyses all combined with high sensitivity and specificity, especially in female patients. The sensitivity and specificity of ABI to predict CAD in total were 79.69% and 71.52%, for male were 72.21% and 73.98%, and for female were 89.52% and 78.23%, respectively. The difference in sensitivity between our research and previous reports was considered to be associated with volunteers choose. The studies included in the review were mainly population-based cohort studies of relatively healthy individuals and people with suspected PAD who were referred to a vascular laboratory. However, we focused on the patients with type 2 diabetes and suggested diabetes patients to pay close attention to screening CAD when ABI value lower than 1.05, especially in Chinese females.
In this study, we additionally found the gender difference was existed in CAD risk between male and female patients with the same ABI level. Taking normal-ABI group as the referent, the positive association between CAD and low-ABI level was observed in nonadjusted model (OR, 17.59; 95% CI, 5.22-83.88). In female patients, this OR value was increased to 24.40 (95% CI, 6.79-60.32; both P < 0.01).
After adjusted for age, duration, and other associated variables, this positive association between CAD and low-ABI level still existed (for male: OR, 2.95; 95% CI, 1.02-9.17; for female: OR, 10.63; 95% CI, 3.42-17.82; both P < 0.01). The OR value in female patients was three-times higher than that of male in adjusted model, which means female patients could take much higher risk of CAD than males among patients with PAD. Moreover, using the ROC analysis, we compared the predictive value of ABI in hinting CAD in both male and female.
ROC analysis showed that for female patients, the optimal cut-off point of ABI value for predicting CAD was lower but the sensitivity and specificity was higher than male patients (for male: cut-off value, Postmenopausal oestrogen was widely believed to have cardioprotective properties, based primarily on anecdotal evidence from a wide range of publications. The risk of CVD increases markedly after the cessation of ovarian function at menopause. 20 The association between the decline in ovarian function and vascular disease was complex because the menopausal transition was always associated with significant changes in the vascular system, distribution of body fat, blood pressure, and blood lipid levels, all of which increase the risk of CVD. 21 It was surprising when several large prospective studies, the Women's Health Initiative, and the heart and oestrogen/ progestin replacement study found that hormone replacement therapy was not beneficial to reduce CVD. Though oestrogen, mediated by oestrogen receptor, could produce various kinds of effects on cardiovascular function.
22,23
The prospective diabetes study (UK Prospective Diabetes Study
[UKPDS]) reported that strict control of blood glucose can obviously reduce the vascular complications in patients with type 2 diabetes. 24 Long-term hyperglycaemic state resulted in vascular endothelial cell damage, thrombosis and lipid deposition, and further formation of atherosclerosis plaque. 25 Our study also indicated that HbA 1c level was positively associated with CAD and it was the independent risk factors for CAD. And we did not find any association between the presence of hypertension with CAD as UKPDS suggested 24 ; however, a positive relationship between SBP and CAD was detected. This may be caused by that most of patients with diagnosed hypertension recruited in our study were receiving hypotensive therapy in our hospital and/or the hypertension was dominated with a higher SBP not DBP among our participants as the descriptive data illustrated. Besides, our study emphasized the close relationship between dyslipidaemia and CAD.
The patients with CAD had significantly higher TC and HDL-C level but lower HDL-C level. Serum TC, HDL-C, and LDL-C level were also independent risk factors for CAD. According to the recommendations of National Lipid Association published in 2014, patients with CAD should control LDL-C level < 2.6 mmol/L to prevent main adverse cardiovascular and cerebrovascular events. 26 Some limitations of this study should also be considered. First, the number of the samples was relatively small, and recruited patients were slightly older population. Besides, it was a cross-sectional study, lacking the long-term outcome of CAD in patients with low ABI. What is important, the value of ABI alone in predicting CAD could not be confirmed in this cross-sectional study, and it needs further followup study to identify the detailed association and the underlying mechanism between the low-ABI level and the CAD in type 2 diabetes population.
In summary, ABI is an independent impact factor of CAD in the Chinese type 2 diabetes population. It hints more than ninefold risk of CAD when the ABI is less than 0.9 in female patients with type 2 diabetes. What is more, the cut-off point of ABI value for predicting CAD was higher than PAD, which means patients could suffer from CAD before diagnosed with PAD. The ABI, used to screen PAD, may be a helpful way and a potential pathogenic factor of CAD. The further study about the underlying link between ABI and CAD in the future may provide a potential strategy for the prevention and treatment of CAD in populations with diabetes.
